Article 1:

The Optimal Age to Stop Endoscopic Surveillance of Patients With Barrett’s Esophagus Based on Sex and Comorbidity: A Comparative Cost-Effectiveness Analysis
Omidvari et al.
Gastroenterology 2021;161:487–494

DOI: https://doi.org/10.1053/j.gastro.2021.05.003
PDF: Article

Summary: Current guidelines recommend surveillance for patients with nondysplastic Barrett’s esophagus (NDBE) but do not include a recommended age for discontinuing surveillance. This study aimed to determine the optimal age for last surveillance of NDBE patients stratified by sex and level of comorbidity.  Comparative modeling analysis illustrates the importance of considering comorbidity status and sex when deciding on the age to discontinue surveillance in patients with NDBE

Presenter: Anthony Horton

Article 2:

Benchmarking Adenoma Detection Rates for Colonoscopy: Results From a US-Based Registry
Shaukat et al.
The American Journal of Gastroenterology: September 2021 – Volume 116 – Issue 9 – p 1946-1949

DOI: https://doi.org10.14309/ajg.0000000000001358
PDF: Article

Summary: Adenoma detection rate (ADR) is highly variable across practices, and national or population-based estimates are not available. Our aim was to study the ADR, variability of rates over time, and factors associated with detection rates of ADR in a national sample of patients undergoing colonoscopy. The average ADR from a large national US sample standardized to the US population is 39.05% and has increased over time.

Presenter: Claire Dorsey